Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03774134

Five Year Oncological Outcome After CME for Sigmoid Colon Cancer

Sponsor: Nordsjaellands Hospital

View on ClinicalTrials.gov

Summary

Study based in existing databases investigating the causal oncological treatment effects of complete mesocolic excision on UICC stage I-III sigmoid colon cancer

Official title: Five Year Oncological Outcome After Complete Mesocolic Excision for Sigmoid Colon Cancer: a Population-based Cohort Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

920

Start Date

2008-06-01

Completion Date

2025-12-31

Last Updated

2024-06-26

Healthy Volunteers

No

Interventions

PROCEDURE

Complete mesocolic excision

Based on the principles of CME. The inferior mesenteric artery (IMA) was divided at its origin from the aorta to perform central lymph nodes dissection along the IMA between the aorta and the branching of the left colic artery. Sigmoid resection included the complete sigmoid colon and resection of the upper part of the rectum to ensure sufficient perfusion of the colo-rectal anastomosis. To achieve sufficient distance at the proximal bowel resection margin, parts of the descending colon or even left hemicolectomy were performed at the surgeon's discretion.

PROCEDURE

Conventional colon resection

The patients underwent what was considered standard colon cancer resections in Denmark during the study period.